Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Yufei JiangKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.
Weida LiangKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.
Binbin WangKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.
Quanshou FengKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.
Chenglong XiaKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.
Qiyao WangNingbo Key Laboratory of Behaviour Neuroscience, Zhejiang Province Key Laboratory of Pathophysiology, School of Medicine, Ningbo University Ningbo 315211 China cuiwei@nbu.edu.cn.
Yinghua YanKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.ORCID https://orcid.org/0000-0002-0569-2881
Lingling ZhaoKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.ORCID https://orcid.org/0000-0002-2577-3363
Wei CuiNingbo Key Laboratory of Behaviour Neuroscience, Zhejiang Province Key Laboratory of Pathophysiology, School of Medicine, Ningbo University Ningbo 315211 China cuiwei@nbu.edu.cn.
Hongze LiangKey Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University Ningbo 315211 China lianghongze@nbu.edu.cn.ORCID https://orcid.org/0000-0002-8278-2258
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
In this study, new magnetic nanoparticles (denotated as Fe
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Magnetic mesoporous silica nanoparticles modified by phosphonate functionalized ionic liquid for selective enrichment of phosphopeptides. · full record | OpenQuestion